ArticleMedicine2025
Exploring the role of palmitoylation-related genes in atrial fibrillation and analysis of immune cell infiltration.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the potential roles and mechanisms of palmitoylation-related key enzymes in atrial fibrillation (AF). AF gene expression data were obtained from the Gene Expression Omnibus database, and differentially expressed genes were screened. Thirty palmitoylation-related enzymes were selected, and differentially expressed palmitoylation-related genes (DPRGs) were further screened. Random Forest, Support Vector Machine-Recursive Feature Elimination, and Least Absolute Shrinkage and Selection Operator regression were used to screen DPRGs, and the intersection was taken as key palmitoylation-related genes (KPRGs). Their diagnostic performance was evaluated. Gene set enrichment analysis and gene set variation analysis were utilized to analyze the correlation between KPRGs and pathways, as well as their correlation with immune cells. Ten DPRGs were screened from the dataset (6 upregulated, 4 downregulated). Three algorithms yielded 6 KPRGs. Receiver operating characteristic curve analysis showed that the combined area under the curve value of the 6 KPRGs was 0.827, indicating good diagnostic performance. Gene set enrichment analysis revealed that KPRGs were related to pathways such as extracellular matrix-receptor interaction, while gene set variation analysis showed positive and negative correlations with multiple pathways. Immune cell infiltration analysis demonstrated significant differences in the infiltration of 5 immune cell types in AF myocardial tissue, which were correlated with KPRGs expression. This study, for the first time, used bioinformatics techniques to screen and identify 6 key palmitoylation enzymes closely related to AF. These genes exhibit good diagnostic performance and are significantly correlated with multiple pathways and immune cell infiltration, providing clues for the study of AF mechanisms and the identification of therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.